Actively Recruiting
Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery
Led by The Second Hospital of Shandong University · Updated on 2022-11-16
350
Participants Needed
1
Research Sites
403 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Objective: The adoption of Enhanced Recovery Surgery programs in lung resection is relatively recent with limited outcome data. This study aimed to determine the impact of an Enhanced Recovery Surgery pathway on short- term and long- term results in patients undergoing lung resection for primary lung cancer. Methods: A Randomized Controlled Trial was designed to collect the perioperative data on consecutive patients undergoing lung resection for primary lung cancer. Patients will be randomizely assigned to the ERAS- Group and Control- Group. Short-term and long- term effect will be compared between the two groups.
CONDITIONS
Official Title
Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with stage I-IIIa Non-small-cell Lung Cancer who underwent radical resection
- Patients with benign lung lesions needing video-assisted thoracoscopic surgery (VATS)
You will not qualify if you...
- Cardio-pulmonary function that cannot tolerate surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yunpeng Zhao
Jinan, Shandong, China, 250033
Actively Recruiting
Research Team
Y
Yunpeng Zhao, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here